Antidepressants for smoking cessation

Cited by (1,000)

Items 701–800 of 1,000

1. Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking
   Natalie K. Walker, Colin Howe, Chris Bullen, Hayden J. McRobbie, Marewa Glover, Varsha Parag, Jonathan A. Williman, Reon Veale, Vili Hapaki Nosa, Joanne Barnes · 2011 · BMC Public Health
2. Evaluation of a Mass Media Campaign Promoting Using Help to Quit Smoking
   Laura Gibson, Sarah Parvanta, Michelle Jeong, Robert Hornik · 2014 · American Journal of Preventive Medicine
3. Utilization of smoking-cessation pharmacotherapy among chronic obstructive pulmonary disease (COPD) and lung cancer patients
   Varun Vaidya, Meghan Hufstader Gabriel, Nilesh Gangan, Surbhi Shah, Robert A. Bechtol · 2014 · Current Medical Research and Opinion
4. Pharmacotherapeutic Management of Nicotine Dependence in Pregnancy
   Shannon M. Clark, Ramzy Nakad · 2011 · Obstetrics and Gynecology Clinics of North America
5. Prioritizing Genes Related to Nicotine Addiction Via a Multi-source-Based Approach
   Xinhua Liu, Meng Liu, Xia Li, Lihua Zhang, Rui Fan, Ju Wang · 2014 · Molecular Neurobiology
6. Trends in utilization of smoking cessation agents before and after the passage of FDA boxed warning in the United States
   Drishti Shah, Anuj Shah, Xi Tan, Usha Sambamoorthi · 2017 · Drug and Alcohol Dependence
7. Smoking cessation treatment: pharmacogenetic assessment.
   Marcus Robert Munafo, Caryn E. Lerman, RAYMOND S. NIAURA, Alexandra E. Shields, Gary E. Swan · 2005 · PubMed
8. Effects of co-administration of bupropion and nicotinic agonists on the elevated plus-maze test in mice
   M. Carmen Carrasco, Paloma Vicens, Jose Vidal, Rosa Redolat · 2006 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
9. Novel Pharmacological Approaches to Drug Abuse Treatment
   Ellen Lockard Edens, Alfredo A. Massa, Ismene L. Petrakis · 2009 · Current topics in behavioral neurosciences
10. Protocol for the Proactive Or Reactive Telephone Smoking CeSsation Support (PORTSSS) trial
    Tim J Coleman, Andy McEwen, Linda Bauld, Janet Ferguson, Paula Kate Lorgelly, Sarah Lewis · 2009 · Trials
11. Varenicline in smoking cessation
    Serena Tonstad, Hans Rollema · 2010 · Expert Review of Respiratory Medicine
12. Association Between Psychotropic Medication Polypharmacy and an Objective Measure of Balance Impairment Among Middle-Aged Adults: Results from the US National Health and Nutrition Examination Survey
    Natalie Bareis, Trisha A. Sando, Briana R. Mezuk, Steven A. Cohen · 2018 · CNS Drugs
13. The impact of chronic bupropion on plasma cotinine and on the subjective effects of ad lib smoking: A randomized controlled trial in unmotivated smokers
    Sarwar Hussain, Laurie A. Zawertailo, Usoa E. Busto, Martin H. Zack, Peter Farvolden, Peter L. Selby · 2009 · Addictive Behaviors
14. Evaluación económica del empleo de terapias farmacológicas para la cesación en el hábito tabáquico
    Fernando Antoñanzas, F. Portillo · 2003 · Gaceta Sanitaria
15. Cardiovascular prevention in the Hartslag Limburg project: Effects of a high-risk approach on behavioral risk factors in a general practice population
    Janneke Harting, Patricia van Assema, Patrick van Limpt, Ton Gorgels, Jan W. van Ree, Erik Ruland, Frank Vermeer, Nanné K. de Vries · 2006 · Preventive Medicine
16. Amphetamine‐like stimulant cessation in an abusing patient treated with bupropion
    Sophie Tardieu, Y. Poirier, Joëlle Micallef, Olivier J. Blin · 2004 · Acta Psychiatrica Scandinavica
17. Biomarkers to Optimize the Treatment of Nicotine Dependence
    Robert A. Schnoll, Frank T. Leone · 2011 · Biomarkers in Medicine
18. Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence
    Jacques Le Houezec, Henri‐Jean Aubin · 2013 · Expert Opinion on Pharmacotherapy
19. How to manage cigarette smoking in kidney transplant candidates and recipients?
    Arnaud Devresse, Sophie T. Gohy, Arnaud Robert, Nada Kanaan · 2021 · Clinical Kidney Journal
20. The use of biomarkers to guide precision treatment for tobacco use
    Scott D. Siegel, Hilary Aurora Tindle, Andrew W. Bergen, Rachel Fynvola Tyndale, Robert A. Schnoll · 2023 · Addiction Neuroscience
21. Real-world tobacco cessation practice in China: findings from the prospective, nationwide multicenter China National Tobacco Cessation Cohort Study (CNTCCS)
    Zhao Liu, Anqi Cheng, Xuejun Hu, Lijun Liu, Suqin Xu, Guochao Shi, Hong Zhou, Jing Bai, Chunmei Zhang, Yong Qi et al. · 2023 · The Lancet Regional Health - Western Pacific
22. Physical Activity as a Protective Factor in Relapse Following Smoking Cessation in Participants with a Depressive Disorder
    Paquito Bernard, Grégory Ninot, Sébastien Guillaume, Guillaume B. Fond, Philippe Courtet, Marie‐Christine Picot, Xavier Quantin · 2012 · American Journal on Addictions
23. Different treatment benefits were estimated by clinical trials performed in adults compared with those performed in children
    Perrine Janiaud, A. Lajoinie, Fleur Cour‐Andlauer, Catherine Cornu, Pierre Cochat, Michel Cucherat, François Gueyffier, Behrouz Kassaï · 2015 · Journal of Clinical Epidemiology
24. Addressing the topic of smoking cessation in a dental setting
    Vivian I. Binnie · 2008 · Periodontology 2000
25. A pragmatic, randomized, controlled study evaluating the impact of access to smoking cessation pharmacotherapy coverage on the proportion of successful quitters in a Canadian population of smokers motivated to quit (ACCESSATION)
    Peter L. Selby, Gerald Brosky, PAUL I. OH, Vincent Raymond, Carmen Arteaga, Suzanne Ranger · 2014 · BMC Public Health
26. Promoting tobacco cessation via the workplace: opportunities for improvement: Table 1
    M. Courtney Hughes, Emily Yette, Peggy A. Hannon, Jeffrey R. Harris, Nguyet Tran, Terry Reid · 2011 · Tobacco Control
27. Telephone care coordination for smokers in VA mental health clinics: protocol for a hybrid type-2 effectiveness-implementation trial
    Erin Rogers, Senaida Fernandez, Colleen C. Gillespie, David A. Smelson, Hildi Hagedorn, Brian D. Elbel, David Kalman, Alfredo Axtmayer, Karishma Kurowski, Scott E. Sherman · 2013 · Addiction Science & Clinical Practice
28. Minding the brain: the role of pharmacotherapy in substance-use disorder treatment
    Elias Dakwar, Herbert D. Kleber · 2017 · Dialogues in Clinical Neuroscience
29. Negative affect as a mediator of the relationship between vigorous-intensity exercise and smoking
    Candyce D. Tart, Teresa M. Leyro, Ashley A. Richter, Michael J. Zvolensky, David Rosenfield, Jasper A. J. Smits · 2010 · Addictive Behaviors
30. A research agenda for assessing the potential contribution of genomic medicine to tobacco control
    Wayne Hall · 2007 · Tobacco Control
31. Was John Reid right? Smoking, class, and pleasure: A population-based cohort study in England
    Iain Lang, Elizabeth A. Gardener, Felicia A. Huppert, David R. Melzer · 2007 · Public Health
32. Rational antidepressant selection: applying evidence-based medicine to complex real-world patients.
    Mark Zetin, Cara T. Hoepner, Lynda Bjornson · 2006 · PubMed
33. Subjective and objective status and health: A response to Adler's “When one's main effect is another's error: Material vs. psychosocial explanations of health disparities. A commentary on Macleod et al., “Is subjective social status a more important determinant of health than objective social status? Evidence from a prospective observational study of Scottish men” (61(9), 2005, 1916–1929) (doi:10.1016/j.socscimed.2006.03.018)
    John Macleod, George Davey Smith, Chris D. Metcalfe, Carole Hart · 2006 · Social Science & Medicine
34. Well-being and harm reduction, the consolidated reality of electronic ciga rettes ten years later from this emerging phenomenon: A narrative review
    Pasquale Caponnetto · 2020 · Health Psychology Research
35. Uninsured South Florida vascular surgery patients are less likely to receive optimal medical management than their insured counterparts.
    Da-Ming Yeh, Monique Jones, C. Schulman, J. Karmacharya, O. Velazquez · 2010 · Journal of Vascular Surgery
36. Interoceptive conditioning with a nicotine stimulus is susceptible to reinforcer devaluation.
    Steven T. Pittenger, Rick A. Bevins · 2013 · Behavioral Neuroscience
37. Medicalisation, smoking and e-cigarettes: evidence and implications
    Kylie Morphett, Adrian Carter, Wayne Hall, CORAL E. GARTNER · 2016 · Tobacco Control
38. Nigerian dental students? compliance with the 4As approach to tobacco cessation
    AO Ehizele, Clement Chinedu Azodo, Ejike B Ezeja, O Ehigiator · 2015 · Journal of preventive medicine and hygiene
39. Involvement of neuronal β 2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: Implications for pharmacotherapies
    Steven J. Simmons, Thomas J. Gould · 2014 · Journal of Clinical Pharmacy and Therapeutics
40. A randomised trial of glucose tablets to aid smoking cessation
    Robert West, Sylvia May, Andy McEwen, Hayden J. McRobbie, Peter Hájek, Eleni Vangeli · 2009 · Psychopharmacology
41. Evidence-Based Patient Safety Advisory: Patient Assessment and Prevention of Pulmonary Side Effects in Surgery. Part 2—Patient and Procedural Risk Factors
    Phillip C. Haeck, Jennifer Swanson, Ronald E. Iverson, Dennis J. Lynch · 2009 · Plastic & Reconstructive Surgery
42. Attention bias in nicotine withdrawal and under stress.
    Danielle E. McCarthy, Rebecca Gloria, John Joseph Curtin · 2009 · Psychology of Addictive Behaviors
43. Tobacco addiction and smoking cessation in Austrian migrants: a cross-sectional study
    Matthias Helmut Urban, Otto Chris Burghuber, Canan Dereci, Masite Aydogan, Eldin Selimovic, Selmir Catic, Georg‐Christian Funk · 2015 · BMJ Open
44. A pro-active approach. Health Promotion and Ill-health prevention
    Tammy Boyce, Stephen Peckham, Alison Hann, Susan Trenholm · 2010
45. Smoking cessation
    Prasima Srivastava, Graeme P. Currie, John R Britton · 2006 · BMJ
46. Neuroscience of Drugs and Addiction
    Trevor William Robbins, Rudolf N. Cardinal, Patricia Di Ciano, Peter W. Halligan, Kim Hellemans, Jonathan L. C. Lee, Barry J. Everitt · 2007 · Elsevier eBooks
47. What can we do in secondary prevention of cigarette smoking?
    Knut-Olaf Haustein · 2003 · European Journal of Cardiovascular Prevention & Rehabilitation
48. Tobacco smoking as a chronic disease: notes on prevention and treatment
    Vikas Batra, Ashwin A. Patkar, Sandra Weibel, Frank T. Leone · 2002 · Primary Care Clinics in Office Practice
49. Employer-sponsored insurance coverage of smoking cessation treatments.
    Douglas E. Levy · 2006 · PubMed
50. Current and Emerging Pharmacotherapeutic Options for Smoking Cessation
    Kristin Carson‐Chahhoud, Malcolm P Brinn, Thomas A. Robertson, Rachada To-A-Nan, Adrian Esterman, Matthew J. Peters, Brian J. Smith · 2013 · Substance Abuse Research and Treatment
51. Incidence and risk factors for five-year recurrent disc herniation after primary single-level lumbar discectomy
    Jonathan H. Geere, Girish Nanjunda Swamy, Paul Raymond Hunter, Jo‐Anne Geere, Lennel N. Lutchman, Andrew J. Cook, Amarjit S. Rai · 2023 · The Bone & Joint Journal
52. Introducing Quin: The Design and Development of a Prototype Chatbot to Support Smoking Cessation
    Hollie Bendotti, David Ireland, Sheleigh Lawler, David Oates, CORAL E. GARTNER, Henry Marshall · 2023 · Nicotine & Tobacco Research
53. A systematic review of quality and cost–effectiveness derived from Markov models evaluating smoking cessation interventions in patients with chronic obstructive pulmonary disease
    F.W. Kirsch · 2015 · Expert Review of Pharmacoeconomics & Outcomes Research
54. Chronic fluoxetine ameliorates adolescent chronic nicotine exposure-induced long-term adult deficits in trace conditioning
    Connor, David A., Gould, Thomas J. · 2017 · Neuropharmacology
55. Largely ignored: the impact of the threshold value for a QALY on the importance of a transferability factor
    Pepijn Vemer, Maureen Rutten‐van Mölken · 2010 · The European Journal of Health Economics
56. STin2 VNTR polymorphism is associated with comorbid tobacco use and mood disorders
    Márcia Regina Pizzo de Castro, Sandra Odebrecht Vargas Nunes, Roberta Losi Guembarovski, Carolina Batista Ariza, Julie Massayo Maeda Oda, Heber Odebrecht Vargas, de Melo, Maria Angélica Ehara Watanabe, Michael Berk, Michael H. J. Maes · 2014 · Journal of Affective Disorders
57. A randomised controlled pilot study of standardised counselling and cost-free pharmacotherapy for smoking cessation among stroke and TIA patients
    Sophia Papadakis, Debbie Aitken, Sophia Gocan, Dana L. Riley, Mary Ann Laplante, Abha Bhatnagar-Bost, Donna Cousineau, Danielle Simpson, Rojiemiahd Edjoc, Andrew Pipe et al. · 2011 · BMJ Open
58. La importancia de tratar la dependencia tabáquica
    Hayden J. McRobbie, Simon Thornley · 2008 · Revista Española de Cardiología
59. Self-help materials for the prevention of smoking relapse: study protocol for a randomized controlled trial
    Fujian Song, Richard Holland, Garry Barton, Max Oscar Bachmann, Annie Blyth, Vivienne Maskrey, Paul N Aveyard, Stephen R. Sutton, Jo Leonardi‐Bee, Thomas Henry Brandon · 2012 · Trials
60. Do paediatricians provide brief intervention for adolescents who smoke?
    Bronwyn Milne, Susan Joy Towns · 2007 · Journal of Paediatrics and Child Health
61. Behavioral Reactivity and Addiction: The Adaptation of Behavioral Response to Reward Opportunities
    Jodie A. Trafton, Elizabeth V. Gifford · 2008 · Journal of Neuropsychiatry
62. Functional Connectivity of the Raphe Nuclei: Link to Tobacco Withdrawal in Smokers
    Paul Faulkner, Dara G. Ghahremani, Rachel Fynvola Tyndale, Gerhard Hellemann, Edythe D. London · 2018 · The International Journal of Neuropsychopharmacology
63. The efficacy of the combination of sertraline with buspirone for smoking cessation
    Jorge Luiz Carrão, Leila Beltrami Moreira, Flávio Danni Fuchs · 2007 · European Archives of Psychiatry and Clinical Neuroscience
64. Rimonabant for treating tobacco dependence.
    Michael B. Steinberg, Jonathan Foulds · 2007 · PubMed Central
65. Tobacco Addiction and Pharmacogenetics of Nicotine Metabolism
    Gary E. Swan, Christina N. Lessov‐Schlaggar · 2009 · Journal of Neurogenetics
66. Exploring the barriers and facilitators to the uptake of smoking cessation services for people in treatment or recovery from problematic drug or alcohol use: A qualitative systematic review
    Eric Osayemwenre Iyahen, Osazee Omoregbe Omoruyi, Neneh Rowa‐Dewar, Fiona Dobbie · 2023 · PLoS ONE
67. Do implementation issues influence the effectiveness of medications? The case of nicotine replacement therapy and bupropion in UK Stop Smoking Services
    Andy McEwen, Robert West · 2009 · BMC Public Health
68. Les outils du sevrage tabagique en 2018
    J. Abdul-Kader, Guillaume Airagnes, Samuel d’Almeida, Frédéric Limosin, Anne-Laurence Le Faou · 2018 · Revue de Pneumologie Clinique
69. Beyond “Safe and Effective”: The urgent need for high-impact smoking cessation medications
    Laura Rosen, Tal Galili, Jeffrey Kott, Vaughan W. Rees · 2021 · Preventive Medicine
70. Frequently Reported Adverse Events With Smoking Cessation Medications: Post Hoc Analysis of a Randomized Trial
    Jon O. Ebbert, Carlos Andrés Jimenez-Ruiz, Michael P. Dutro, Matt Fisher, Jing Li, James Taylor Hays · 2021 · Mayo Clinic Proceedings
71. Optimal use of smoking cessation pharmacotherapy
    Colin Paul Mendelsohn · 2022 · Australian Prescriber
72. Cardiovascular Prevention (IV) The Importance of Treating Tobacco Dependence
    Hayden J. McRobbie, Simon Thornley · 2008 · Revista Española de Cardiología (English Edition)
73. Contingency management for behavior change: Applications to promote brief smoking cessation among opioid-maintained patients.
    Kelly E. Dunn, Kathryn A. Saulsgiver, Stacey C. Sigmon · 2011 · Experimental and Clinical Psychopharmacology
74. Repeated nicotine exposure in adolescent rats: Reduction of medial habenular activity and augmentation of nicotine preference
    Hyunchan Lee, Miseon Kang, Jun-Mo Chung, Jihyun Noh · 2014 · Physiology & Behavior
75. Combining intensive practice nurse counselling or brief general practitioner advice with varenicline for smoking cessation in primary care: Study protocol of a pragmatic randomized controlled trial
    Carolien van Rossem, Mark Spigt, Eline Suzanne Smit, Wolfgang Viechtbauer, Katinka Mijnheer, Onno C. P. van Schayck, Daniel Kotz · 2015 · Contemporary Clinical Trials
76. Intention to quit moderates the effect of bupropion on smoking urge
    Jennifer W. Tidey, Damaris J. Rohsenow · 2009 · Nicotine & Tobacco Research
77. Smoking as a Disease
    Dae Hyun Kim, Young Sung Suh · 2009 · Korean Journal of Family Medicine
78. Sustained-Release Bupropion for Smoking Cessation in a Chinese Sample: A Double-Blind, Placebo-Controlled, Randomized Trial
    Lihan Sheng, Y.-l. Tang, Zuo-Ning Jiang, C.-h. Yao, J.-y. Gao, G.Z. Xu, X.-y. Tong · 2012 · Nicotine & Tobacco Research
79. A randomized controlled trial of the efficacy and safety of varenicline for smoking cessation after acute coronary syndrome: Design and methods of the Evaluation of Varenicline in Smoking Cessation for Patients Post-Acute Coronary Syndrome trial
    Sarah B. Windle, Iqbal R. Bata, Mina Madan, Beth L. Abramson, Mark Jeffrey Eisenberg · 2015 · American Heart Journal
80. Postnatal Cardiovascular Consequences in the Offspring of Pregnant Rats Exposed to Smoking and Smoking Cessation Pharmacotherapies
    Kathirvel Gopalakrishnan, A. More, G. Hankins, T. Nanovskaya, Sathish Kumar · 2017 · Reproductive Sciences
81. Nicotine Addiction: Past and Present
    Office on Smoking · 2010
82. Management of Chronic Obstructive Pulmonary Disease
    Robert M Ewart · 2004 · JAMA
83. Lung cancer screening in Brazil: recommendations from the Brazilian Society of Thoracic Surgery, Brazilian Thoracic Association, and Brazilian College of Radiology and Diagnostic Imaging
    Luiz Fernando Ferreira Pereira, Ricardo Sales dos Santos, Daniel Oliveira Bonomi, Juliana Franceschini, Ilka Lopes Santoro, André Miotto, Thiago Lins Fagundes de Sousa, Rodrigo Caruso Chate, Bruno Hochhegger a, Artur Gomes Neto et al. · 2024 · Jornal Brasileiro de Pneumologia
84. Systematic review and meta-analysis of the impact of depression on subsequent smoking cessation in patients with chronic respiratory conditions
    Shu Ying Ho, Nora Alnashri, Daniela Rohde, Paul Murphy, Frank Doyle · 2015 · General Hospital Psychiatry
85. Systematic reviews on tobacco control from Cochrane and the Community Guide: different methods, similar findings
    Laura Rosen, Michal Ben Noach · 2010 · Journal of Clinical Epidemiology
86. Tratamento farmacológico do tabagismo
    Guilherme Rubino de Azevedo Focchi, Ivan Mário Braun · 2005 · Archives of Clinical Psychiatry (São Paulo)
87. Changes in salivary proteome before and after cigarette smoking in smokers compared to sham smoking in non-smokers: A pilot study
    Indu Sinha, Jennifer L. Modesto, Nicolle M. Krebs, Anne E. Stanley, Vonn Walter, John P. Richie, Joshua E. Muscat, Raghu Sinha · 2021 · Tobacco Induced Diseases
88. A Testable Prognostic Model of Nicotine Dependence
    Rachel Badovinac Ramoni, Nancy L. Saccone, Dorothy K. Hatsukami, Laura Jean Bierut, Marco F. Ramoni · 2009 · Journal of Neurogenetics
89. Pharmacologic Agents for Tobacco Dependence Treatment: 2011 Update
    James Taylor Hays, David D. McFadden, Jon O. Ebbert · 2011 · Current Atherosclerosis Reports
90. A game for smokers: A preliminary naturalistic trial in a psychiatric hospital
    Yasser Khazaal, Anne Chatton, Roberto Prezzemolo, Aliosca Hoch, Jacques Cornuz, DANIELE FABIO ZULLINO · 2008 · Patient Education and Counseling
91. Does cigarette reduction while using nicotine replacement therapy prior to a quit attempt predict abstinence following quit date?
    Nicola Lindson, Bethany Shinkins, Robert West, Susan Michie, Paul N Aveyard · 2016 · Addiction
92. Treatment of mild chronic obstructive pulmonary disease
    Don D. Sin · 2008 · International Journal of COPD
93. Predictors of cessation in smokers suspected of TB: Secondary analysis of data from a cluster randomized controlled trial
    Helen Elsey, Omara F. Dogar, Jasjit S. Ahluwalia, Kamran Siddiqi · 2015 · Drug and Alcohol Dependence
94. Pharmacologic agents for smoking cessation: A clinical review
    Dilip R. Patel · 2010 · Clinical Pharmacology Advances and Applications
95. Smoking Abstinence Rates and Reasons for Failure to Quit Smoking in Cancer Patients in Jordan
    Feras Ibrahim Hawari, Nour Ali Obeidat, Hamza Mustafa Beano, Sahar Dawahrah, Dalia Al-Rimawi, Iyad M. Ghonimat · 2011 · Respiration
96. Pharmacological treatments for tobacco dependence
    K.O. Fagerström, Carlos Andrés Jimenez-Ruiz · 2008 · European Respiratory Review
97. Prenatal exposure of bupropion may enhance agitation, anxiety responses, and sensitivity to cocaine effects in adult mice.
    Shu-Wen Su, Chian-Fang G. Cherng, Yin Chiu Lin, Lung Yu · 2007 · PubMed
98. The place of varenicline in smoking cessation treatment
    Paul N Aveyard · 2008 · Thorax
99. Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study
    M. Nylænde, A Kroese, B. Morken, E. Stranden, Gunnar Sandbæk, Anne Karin Lindahl, Harald Arnesen, Ingebjørg Seljeflot · 2007 · Vascular Medicine
100. Interventions for smokeless tobacco use cessation
     Jonathan Livingstone‐Banks, Aishwarya Lakshmi Vidyasagaran, Ray Croucher, Faraz Siddiqui, Sufen Zhu, Zainab Kidwai, Tom Parkhouse, Ravi Mehrotra, Kamran Siddiqi · 2025 · Cochrane Database of Systematic Reviews